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p63 is a key regulator of iRHOM2 signalling in the
keratinocyte stress response
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Hyperproliferative keratinocytes induced by trauma, hyperkeratosis and/or inﬂammation
display molecular signatures similar to those of palmoplantar epidermis. Inherited gain-of-
function mutations in RHBDF2 (encoding iRHOM2) are associated with a hyperproliferative
palmoplantar keratoderma and squamous oesophageal cancer syndrome (termed TOC). In
contrast, genetic ablation of rhbdf2 in mice leads to a thinning of the mammalian footpad, and
reduces keratinocyte hyperproliferation and migration. Here, we report that iRHOM2 is a
novel target gene of p63 and that both p63 and iRHOM2 differentially regulate cellular stress-
associated signalling pathways in normal and hyperproliferative keratinocytes. We demon-
strate that p63–iRHOM2 regulates cell survival and response to oxidative stress via mod-
ulation of SURVIVIN and Cytoglobin, respectively. Furthermore, the antioxidant compound
Sulforaphane downregulates p63–iRHOM2 expression, leading to reduced proliferation,
inﬂammation, survival and ROS production. These ﬁndings elucidate a novel p63-associated
pathway that identiﬁes iRHOM2 modulation as a potential therapeutic target to treat
hyperproliferative skin disease and neoplasia.
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Keratinocyte hyperproliferation and inﬂammation arecommon to many skin disorders, from the more prevalentconditions such as psoriasis and atopic eczema to the rarer
monogenic skin diseases which include the palmoplantar kera-
todermas (PPKs). The PPKs are characterised by different pat-
terns of hyperproliferative thickening of the palms and soles,
which are often painful1,2. Furthermore, PPK can also be asso-
ciated with non-cutaneous conditions such as hearing loss, car-
diomyopathy and oesophageal cancer3,4. For example, inherited
dominant mutations in RHBDF2, the gene encoding iRHOM2,
are the genetic basis of the inherited syndrome Tylosis (PPK)
with Oesophageal Cancer (TOC, OMIM: 148500)5.
iRHOM2 is a proteolytically inactive member of the seven
transmembrane family of Rhomboid serine proteases6. iRHOM2
can control activation and trafﬁcking of ADAM17 (also known as
TACE; TNFα converting enzyme) from the endoplasmic reticu-
lum to the Golgi and then to the cell surface7–10. ADAM17 is a
membrane-anchored metalloprotease with a wide range of sub-
strates including cytokines (TNFα), many receptors (IL-6R, TNF-
R), growth factors (TGFα, AREG) and adhesion proteins11. The
autosomal dominant TOC-associated missense mutations, loca-
ted in the highly conserved cytoplasmic amino-terminal domain
of iRHOM2, lead to increased ADAM17 activity and the ‘shed-
ding’ of its associated substrates at the cell surface9. TOC kera-
tinocytes have constitutively high levels of, for example, TGFα,
AREG, IL-6R and IL-6. Thus, TOC-associated iRHOM2 muta-
tions promote cell growth and migration in keratinocytes, which
exhibit a constitutive wound-healing phenotype and display
similar features to the inﬂammatory skin disease psoriasis and
epithelial cancer cell lines5,12.
We have recently described12 an important role for iRHOM2
in the regulation of the epithelial response to physical stress by
identifying Keratin 16 (K16) as a novel interacting binding
partner. TOC-associated iRHOM2 alters the dynamics of K16
regulation, including the hetero-dimerisation with its type II
binding partner K6. In vitro depletion of iRHOM2 in TOC ker-
atinocytes reduced K16 expression, proliferation and pro-
inﬂammatory signalling. In contrast to the hyperproliferative
TOC palmoplantar epidermis, rhbdf2−/− mice have a much
thinner footpad epidermis compared to control mice. This
striking cutaneous phenotype is associated with loss of K16
expression.
In this study, we show the presence of different signalling
mechanisms between normal interfollicular and palmoplantar
epidermis. The stressed palmoplantar epidermis mirrors dis-
orders of keratinocyte hyperproliferation. To date, no studies
have investigated the transcriptional regulation of iRHOM2.
Here, we demonstrate that iRHOM2 is a direct molecular target
of the transcription factor p63, the ‘master regulator’ of epithelial
development13,14. Alteration of p63 expression is observed in
oesophageal cancer, not only in carcinomas, but also in
dysplasia15,16. TP63 is expressed as multiple isoforms from
alternative promoters with either an N-terminal transactivation
(TA) domain or a dominant-negative (ΔN) domain and, in
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Fig. 1 Identiﬁcation of iRHOM2 as a p63 target gene in keratinocytes. a Screenshot of the UCSC genome browser from ChIP-seq analysis of normal human
primary keratinocytes with two different antibodies (4A4, pan-p63 and H129, α-speciﬁc). The ChIP-seq study was previously reported. b Chromatin
immunoprecipitation in control keratinocytes (CTRL) with anti-pan p63 (H137) and anti-IgG antibodies followed by quantitative PCR (ChIP-qPCR) analysis
showed that p63 binds to RHBDF2 intragenic region. Error bars represent SEM of three independent experiments and Student’s two-tailed t-test value is
shown; ***p < 0.001. c Luciferase assay for RHBDF2 gene locus. The construct was transiently transfected into HEK293 cells in the absence (−) or in the
presence of ΔNp63α or TAp63α. The (+) control corresponds to IRF6p229-Luc plasmid. The activity of the intragenic region was measured by luciferase
assay and values are expressed relative to (−) set to 1. Data were analysed using two-tailed Student’s t-test (*p < 0.05, **p < 0.01 and ***p < 0.001). d qRT-
PCR for RHBDF2 in HEK293 cells transfected with TA and ΔNp63 isoforms. The graph represents means and SEM of three biological replicates after 9 h of
transfection. Statistical analysis was performed by Student’s two-tailed t-test comparing pcDNA transfected cells to other samples. e Immunoblotting of
HEK293 cells over-expressing p63 isoforms, showed TA and ΔNp63 isoforms (α-pan p63) and iRHOM2 expression after 9 h of transfection. GAPDH was
used as loading control. The graph represents the means of the quantiﬁcation, using ImageJ software, from three independent experiments relative to
GAPDH. Error bars represent SEM and Student’s two-tailed t-test values are given *p < 0.05. f Representative western blotting (WB) shows expression of
ΔNp63 and iRHOM2 in normal keratinocytes (CTRL) treated with non-targeted protein (NTP) or p63 siRNAs. GAPDH was used as a loading control
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Fig. 2 Distinct regulation of p63 in normal and hyperproliferative keratinocytes. a Representative images of H&E stained sections, displaying a
hyperproliferative epidermis in TOC compared to normal interfollicular skin. Confocal microscopy analysis shows p63 (α-pan p63) expression in TOC and
in control interfollicular skin. DAPI (blue) is used as a nuclear stain. Scale bars: 20 µm. Graph represents quantiﬁcations of p63 expression in ratio with the
nuclei from three human samples. Student’s two-tailed t-test value is shown, **p < 0.01. b Representative H&E stained back skin and fore-paw sections
from 20-week-old rhbdf2+/+ and rhbdf2−/− mice. Scale bar: 20 μm. Confocal analysis of p63 (α-pan p63) expression was performed in back skin and fore-
paw sections of rhbdf2+/+ and rhbdf2−/− mice. Scale bar: 20 µm. c qRT-PCR for ΔNp63 from mRNA extracted from back skin and fore-paws of rhbdf2+/+
and rhbdf2−/− mice. The graph shows n= 6 of each genotype. The statistical analysis was performed using Student’s two-tailed t-test (*p < 0.05,
**p < 0.01)
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addition, these TAp63 and ΔNp63 transcripts can be alternatively
spliced at the C-terminus to generate proteins designated α, β and
γ13. The ΔNp63α isoform of p63 is expressed at high levels in the
proliferative basal layer of the epidermis, suggesting the impor-
tant role for this isoform in the biology of epithelial cells13. Recent
studies have described that ΔNp63 overexpressing mice exhibit
hyperproliferation, defects in terminal differentiation and an
inﬂamed skin phenotype, demonstrating a key role of ΔNp63 in
inﬂammatory skin disease17,18.
We show that, in normal keratinocytes under physiological
conditions, p63 positively regulates iRHOM2, while iRHOM2
antagonises ΔNp63 expression. In contrast, in hyperproliferative
keratinocytes, there is an auto-regulatory feedback loop occurring
between ΔNp63 and iRHOM2. We show that p63–iRHOM2
mediated signalling regulates ADAM17 activity and cellular
functions including inﬂammation, proliferation, survival and
oxidative defence. Furthermore, we identify SURVIVIN as a
novel binding partner of iRHOM2 and as a p63 target gene. In
addition, we also reveal a role of iRHOM2 in the epidermal
oxidative defence response via its interaction with Cytoglobin
(CYGB), a reported p63 target gene. Our ﬁndings implicate a
novel signalling pathway involving p63 and iRHOM2 in the
control of hyperproliferative skin diseases and squamous oeso-
phageal cancer.
Results
p63 regulates iRHOM2 expression in normal keratinocytes. To
identify transcriptional regulators of iRHOM2, speciﬁcally if the
RHBDF2 gene encoding iRHOM2 may be a direct p63 target, we
analysed an available p63 ChIP-seq data set performed in human
and mouse keratinocytes19,20. This revealed that the human and
mouse p63 binding sites are very well conserved at the intragenic
region (Fig. 1a and Supplementary Fig. 1a). Furthermore, ChIP-
qPCR conﬁrmed that p63 binds to the RHBDF2 gene locus
(Fig. 1b). In addition, ChIP-qPCR analysis for the speciﬁc binding
of p63 was performed with p21 (positive control), Thymidine
kinase (TK, negative control) and a no-gene region (Chr11)
(Supplementary Fig.1b). These data indicate that p63 binds to the
intragenic enhancer region of RHBDF2 and that iRHOM2 is a
direct p63 target gene. In addition, we cloned this speciﬁc
intragenic region, into the pGL3 enhancer plasmid19, and tested
whether the luciferase reporter gene activity is induced by
TAp63α and ΔNp63α in HEK293 cells (human embryonic
kidney cells). As shown in Fig. 1c, both TAp63α and ΔNp63α
markedly upregulated luciferase activity. To further investigate
whether p63 binding to iRHOM2 intragenic region affects
iRHOM2 expression, each p63 isoform (ΔNp63α, ΔNp63β,
ΔNp63γ, TAp63α, TAp63β and TAp63γ) was transiently trans-
fected in HEK293 cells. qRT-PCR and western blot analysis
showed that overexpression of the p63 isoforms modulates
iRHOM2 expression, in particular TAp63α and ΔNp63α sig-
niﬁcantly induce iRHOM2 expression at mRNA and protein
levels (Fig. 1d, e). Additionally, depletion of p63 in keratinocytes
by a small interfering RNA (siRNA) which targets all p63 iso-
forms21 signiﬁcantly reduced endogenous iRHOM2 protein
expression (Fig. 1f) as well as at the mRNA level (Supplementary
Fig. 1c). Our data suggest that ΔNp63α, the major p63 isoform
expressed in epidermis, is also the major p63 isoform that reg-
ulates iRHOM2 in keratinocytes.
To further investigate the expression of iRHOM2 in keratino-
cytes, HaCaT keratinocyte differentiation was induced in vitro by
adding Ca2+ to the culture medium. iRHOM2 expression was
upregulated upon the induction of differentiation in a time-
dependent manner (Supplementary Fig. 1d). ΔNp63, keratin 14
(K14) and involucrin expression was assessed by western blotting
to conﬁrm that the keratinocytes were undergoing differentiation.
As expected, ΔNp63 and K14, highly expressed under prolif-
erative conditions, were reduced upon the induction of
differentiation while involucrin expression was upregulated.
Additionally, we also validated by qRT-PCR the increased
expression of RHBDF2 at mRNA level upon Ca2+ shift
(Supplementary Fig. 1e) and K14 was used as a control of the
differentiation state. Moreover, iRHOM2 is expressed in the
cytoplasm and plasma membrane of the basal and suprabasal
layers of human epidermis (Supplementary Fig. 1f). Taken
together, these results demonstrate that iRHOM2 is a transcrip-
tional target of p63 and suggests that iRHOM2 might be
implicated in the regulation of epidermal differentiation.
Distinct regulation of p63 expression in keratinocytes. Exam-
ination of the morphology of the stratiﬁed epithelia revealed a
thicker epidermis in TOC compared with normal interfollicular
skin as previously reported9,22 (Fig. 2a). Immunohistochemistry
showed increased p63 expression in the nuclei of the basal and
suprabasal layers in TOC epidermis compared to control inter-
follicular skin (Fig. 2a). To better delineate the basal cells of the
epidermis, we also performed immunoﬂuorescence staining for
Keratin 14 (K14), a marker of the basal layer (Supplementary
Fig. 2a). Similarly, in the immortalised TOC keratinocytes,
ΔNp63 was upregulated at the mRNA and protein levels when
compared to control keratinocytes (Supplementary Fig. 2b and
2c). Microscopic examination of haematoxylin and eosin-stained
skin sections showed no signiﬁcant difference in the thickness of
the rhbdf2−/− mice back skin compared to wild-type controls,
while the rhbdf2−/− mice paw revealed a thinner epidermis
compared to rhbdf2+/+ mice as published previously12. Back skin
and footpads from rhbdf2−/− mice were immunostained for p63
and analysed by confocal microscopy (Fig. 2b). rhbdf2−/− mice
showed increased p63 expression in the back skin but had
reduced expression in their footpad epidermis compared to
rhbdf2+/+ littermates (Fig. 2b). K14 was also used to delineate the
basal cells of the epidermis (Supplementary Fig. 2d), as a ‘bona
ﬁde’ target of p63, interestingly, K14 follows the same p63
expression pattern. In addition, we also conﬁrmed modulation of
p63 expression by qRT-PCR and western blot analysis of extracts
derived from paw and back skin of rhbdf2+/+ and rhbdf2−/−
mice (Fig. 2c and Supplementary Fig. 2e). To investigate this
apparent cell-context-dependent regulation of p63 by iRHOM2,
we next used short hairpin RNA (shRNA) knockdown of
iRHOM2, which was found to increase ΔNp63 protein expression
in control keratinocytes, while sh-iRHOM2 TOC keratinocytes
resulted in a downregulation of ΔNp63 expression (Supplemen-
tary Fig. 2f). These observations indicate that, in interfollicular
skin, iRHOM2 represses ΔNp63 expression, whilst in hyperpro-
liferative footpad skin and in TOC keratinocytes, iRHOM2
positively regulates ΔNp63 expression.
iRHOM2–ADAM17 axis regulates p63 expression. iRHOM2
regulates the maturation of the multi-substrate ectodomain
sheddase enzyme ADAM177,8 and, in TOC derived keratinocytes,
there is increased cleavage of ADAM17 substrates such as TNFα,
IL-6R and EGFR ligands compared to control cells (9). TOC
derived keratinocytes exhibit features of a constitutive ‘wound-
healing’ phenotype in which the iRHOM2–ADAM17 axis plays a
key role in skin barrier maintenance, inﬂammation and
migration5,9. Here, the modulation of the iRHOM2–ADAM17
axis on p63 expression was investigated. Western blot analysis
(Fig. 3a) revealed that ADAM17 depletion by siRNA led to an
increase of ΔNp63 in control keratinocytes, whilst ΔNp63
was downregulated in TOC keratinocytes. These data were
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consistent with our data above in iRHOM2 knock-down cells
(Supplementary Fig. 2f). In agreement, inhibition of ADAM17
using the small molecule TMI-005 increased ΔNp63 in control
keratinocytes but decreased its expression in TOC keratinocytes
(Fig. 3b). As TOC-derived keratinocytes display an inﬂammatory
phenotype8,9, we next assessed whether the secretion of growth
factors and cytokines in these cells may regulate the expression of
ΔNp63.
Surprisingly, we found that conditioned media from TOC-
derived keratinocytes reduced ΔNp63 expression (Fig. 3c) in
control cells. As TNFα is known to induce keratinocyte
differentiation and modulate p63 expression23, keratinocytes
treated with PMA (phorbol 12-myristate 13-acetate) showed
downregulation of ΔNp63 expression in control cells (Supple-
mentary Fig. 3a) conﬁrming previous studies24,25. However,
the addition of conditioned media from TOC keratinocytes to
TOC keratinocytes with shRNA-mediated knockdown of
iRHOM2 showed a restoration of ΔNp63 expression (Fig. 3d).
These data suggested that ‘the environment’ of cell surface shed
cytokines and growth factors can regulate ΔNp63 expression in a
cell-context-dependent manner.
To examine this putative p63–iRHOM2–ADAM17 axis
further, western blot analysis of both control and TOC
keratinocytes with p63 siRNA knockdown (Fig. 3e) revealed
hg
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Fig. 3 iRHOM2–ADAM17 axis regulates p63 expression. a Expression of ADAM17 and ΔNp63 by WB in control (CTRL) and TOC keratinocytes transfected
with non-targeting pool (NTP) and ADAM17 siRNA. b Immunoblotting of ΔNp63 expression performed in CTRL and TOC keratinocytes treated with and
without TMI-005 for 24 h. c Immunoblotting for ΔNp63 in CTRL keratinocytes and d in Sh Scr (Scramble) and Sh iRHOM2 TOC keratinocytes treated with
or without conditioned media (CM) for 24 h. GAPDH was used as a loading control. e WB analysis for ΔNp63, iRHOM2 and ADAM17 in normal and TOC
keratinocytes with NTP and p63 siRNA. TUBULIN was used as a loading control. All the quantiﬁcations included were performed by ImageJ software in
comparison to the loading control in three independent experiments. Student’s t test was used, (*p < 0.05 and **p < 0.01). f Levels of TNFα, TGFα and IL-6R
were assessed by ELISA from the supernatant of NTP, p63 and ADAM17 siRNAs in CTRL and TOC keratinocytes. Data are expressed as mean with SEM
from four experiments. Statistical analysis was compared to NTP siRNA CTRL or TOC using one way ANOVA Dunnett’s multiple comparison test (*p <
0.05, **p < 0.01 and ***p < 0.001). g Screenshot of the UCSC genome browser from ChIP-seq analysis of normal human primary keratinocytes with two
different antibodies (4A4, pan-p63 and H129, α-speciﬁc). The ChIP-seq study was previously reported. h Chromatin immunoprecipitation in control
keratinocytes (CTRL) with anti-pan p63 (H137) and anti-IgG antibodies followed by quantitative PCR (ChIP-qPCR) analysis showed that p63 binds to
ADAM17 intragenic region. Error bars represent SEM of three independent experiments. For statistical evaluation Student’s two-tailed ttest was used (**p <
0.01)
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+/+ and rhbdf2−/− mice by confocal microscopy. DAPI (blue) is used as a nuclear stain. Scale bar: 20 µm. f CTRL keratinocyte lysates were
immunoprecipitated using an anti-iRHOM2 antibody and immunoblotted with anti-SURVIVIN antibody. g Screenshot of the UCSC genome browser from
ChIP-seq analysis of normal human primary keratinocytes with two different antibodies (4A4, pan-p63 and H129, α-speciﬁc) for BIRC5, gene encoding
SURVIVIN. The ChIP-seq study was previously reported. h Chromatin immunoprecipitation in control keratinocytes (CTRL) with anti-pan p63 (H137) and
anti-IgG antibodies followed by ChIP-qPCR analysis showed that p63 binds to the BIRC5 intergenic region. Error bars represent SEM of three independent
experiments. For statistical evaluation Student’s two-tailed t test was used (**p < 0.01)
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reduced expression of both iRHOM2 and ADAM17. As TOC
keratinocytes are characterised by increased ADAM17 matura-
tion and shedding of its substrates9, we assessed the role of p63 in
the regulation of ADAM17 protease activity. We demonstrated
that depletion of p63 in both control and TOC keratinocytes
resulted in decreased ADAM17 maturation and consequently, a
reduction in the ‘shedding’ of TGFα, TNFα and IL-6R (Fig. 3f).
To investigate the mechanism by which p63 regulates ADAM17
expression and its downstream pathway, we analysed the
available p63 ChIP-seq data set performed in human and mouse
keratinocytes19,20. This revealed that the human and mouse p63
binding sites are very well conserved at the intragenic region
(Fig. 3g and Supplementary Fig. 3b). Furthermore, ChIP-qPCR
conﬁrmed that p63 binds to the ADAM17 gene locus (Fig. 3h).
These data indicate that ADAM17 is a direct p63 target gene. To
further investigate whether p63 binding to the ADAM17
intragenic region affects ADAM17 expression, p63 isoforms were
transiently transfected in HEK293 cells, following which, qRT-
PCR and western blot analysis showed that overexpression of
TAp63α and ΔNp63α signiﬁcantly induce ADAM17 at both
mRNA and protein level (Supplementary Fig. 3c and 3d).
Similarly, ADAM17 is also known to be a target of p73,
another p53 homologue26, as is p63. Thus, these results revealed
that p63 can directly regulate both iRHOM2 and ADAM17
expression.
Additionally, in our previous study12, we have shown that
downregulation of iRHOM2 in both control and TOC keratino-
cytes was associated with reduced cell proliferation and migra-
tion. Here we found that depletion of p63 also reduced both
proliferation and migration in control and TOC cell lines
(Supplementary Fig. 3e and 3f).
iRHOM2–p63 axis modulates resistance to apoptosis. TOC
epidermis displays improved barrier function, hyperproliferation
and thickening of the palmoplantar regions9,12. As exposure to
ultraviolet B (UV-B) light is an environmental stressor for basal
keratinocytes, we investigated the cellular response in TOC ker-
atinocytes. Upon UV-B treatment, TOC keratinocytes showed
greater resistance to cell death compared to control keratinocytes
as assessed by annexin-V staining using ﬂow cytometry (Fig. 4a).
Furthermore, control and TOC keratinocytes depleted for
iRHOM2 exhibited an induction of apoptosis (Supplementary
Fig. 4a). Depletion of iRHOM2 in TOC keratinocytes increased
sensitivity to UV-B-induced apoptosis (Fig. 4b). Moreover, both
cell lines depleted for p63 demonstrated induction of apoptosis
following UV-B treatment (Supplementary Fig. 4b). These data
suggest that iRHOM2 and p63 are involved in the regulation of
the keratinocyte apoptotic pathway. Understanding the
mechanism(s) through which TOC keratinocytes displayed
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resistance to cell death, the expression of inhibitors of apoptosis
proteins (IAP) was investigated. Western blot analysis revealed an
increased expression of SURVIVIN in TOC keratinocytes com-
pared to control cells whilst expression of the other members of
the IAP family was unchanged (Supplementary Fig. 4c). We also
investigated the effect of UV-B stimulation on iRHOM2, ΔNp63
and SURVIVIN expression by western blot analysis. We ﬁrst
conﬁrmed that the cells undergo apoptosis by assessing the
expression of PARP, and observed lower levels of PARP cleavage
in TOC keratinocytes after UV-B exposure in comparison to
control cells. iRHOM2, ΔNp63 and SURVIVIN expression was
virtually absent in UV-B exposed control keratinocytes but only
slightly lower in TOC keratinocytes (Fig. 4c).
To explore this putative regulation of SURVIVIN by iRHOM2
further, confocal analysis revealed an increase in SURVIVIN
expression in the cytoplasm and the nuclei of basal layer of
keratinocytes in TOC epidermis, compared to control inter-
follicular skin (Fig. 4d). Immunostaining in rhbdf2−/− mouse
skin showed increased levels of SURVIVIN expression in
the back skin but reduced levels in their footpads in comparison
to rhbdf2+/+ littermate controls (Fig. 4e). In addition,
we also conﬁrmed the modulation of SURVIVIN expression by
western blot analysis of protein extracts taken from back
skin and paw of rhbdf2+/+ and rhbdf2−/− mice (Supplementary
Fig. 4d).
In agreement with data obtained from rhbdf2−/− mice,
depletion of iRHOM2 resulted in an increase of SURVIVIN
protein expression in control keratinocytes and a reduction in
TOC keratinocytes (Supplementary Fig. 4e). To further explore
the molecular mechanism by which iRHOM2 regulates SURVI-
VIN, we investigated whether the two proteins are associated in a
complex. Co-immunoprecipitation analysis showed that endo-
genous iRHOM2 was able to efﬁciently immunoprecipitate
SURVIVIN in control keratinocytes (Fig. 4f) and that endogenous
SURVIVIN forms a complex with iRHOM2 (Supplementary
Fig. 4f). Taken together our data demonstrated that iRHOM2 is
involved in the regulation of SURVIVIN.
As the depletion of p63 and iRHOM2 in both control and TOC
keratinocytes induced apoptosis, we explored a possible regula-
tion of SURVIVIN by p63. Prior studies have shown that
SURVIVIN is negatively regulated by wild-type p53 but not
mutated p5327. To identify transcriptional regulators of
BIRC5, gene encoding SURVIVIN, we analysed the available
p63 ChIP-seq data set performed in human and mouse
keratinocytes19,20. This revealed that the human and mouse p63
binding sites are very well conserved at the intergenic region
(Fig. 4g and Supplementary Fig. 4g). ChIP-qPCR revealed that
p63 binds to BIRC5 gene locus (Fig. 4h). These data indicate that
BIRC5 is a direct p63 target gene. To further investigate whether
p63 binding to BIRC5 intergenic region affects SURVIVIN
expression, p63 isoforms were transiently transfected in HEK293
cells. By qRT-PCR analysis, it was found that cells overexpressing
TAp63α and ΔNp63α signiﬁcantly induce BIRC5 at mRNA level
(Supplementary Fig. 4h). Western blotting analysis conﬁrmed the
same results (Supplementary Fig. 4i). In addition, depletion of
p63 by siRNA reduced endogenous expression of SURVIVIN in
both control and TOC keratinocytes (Supplementary Fig. 4j).
These ﬁndings support a model of reciprocal regulation between
iRHOM2 and ΔNp63 in hyperproliferative keratinocytes that may
play a role in the resistance to apoptosis via modulation of
SURVIVIN.
iRHOM2–p63 axis regulates oxidative stress. Previous studies
have shown that oxidative stress contributes to a form of pal-
moplantar keratoderma (pachyonychia congenita)28, as well as
inﬂammation29, and may suppress apoptosis and promote pro-
liferation30. Therefore, we investigated whether the iRHOM2
pathway could play a role in reactive oxygen species (ROS) reg-
ulation. We examined the production of ROS in the cells using
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dihydroethidium (DHE) dye by ﬂow cytometry. In this assay ROS
convert non-ﬂuorescent DHE to ﬂuorescent ethidium, which
then intercalates into DNA. We found that TOC keratinocytes
showed increased level of ROS compared to control cells (Fig. 5a).
However, a reduction in DHE stained cells was observed in both
control and TOC keratinocytes depleted for iRHOM2 (Fig. 5b).
We also showed a signiﬁcant decrease of ROS level in control and
TOC keratinocytes depleted for iRHOM2 by ﬂow cytometry
(Supplementary Fig. 5a). Similarly, we also assessed the role of
p63 in the regulation of ROS. An increase of ROS production in
control keratinocytes depleted for p63 was observed while the
levels were downregulated in TOC cells silenced for p63 (Sup-
plementary Fig. 5b).
In order to explore a potential mechanism through which the
p63–iRHOM2 axis may control oxidative stress in TOC
keratinocytes, we evaluated the expression of genes associated
with antioxidant pathways such as NQO1 (NAD-(P)H:quinone
oxidoreductases), HMOX1 (Haem Oxygenase 1), SOD1 (Super-
oxide Dismutase 1) and CYGB (Cytoglobin) by qRT-PCR. We
observed a downregulation of these antioxidant genes in TOC
keratinocytes compared to control (Fig. 5c) which is correlated
with the increased levels of ROS in TOC keratinocytes.
Interestingly, dysregulation of NRF2 was reported to contribute
to palmoplantar keratoderma28. We investigated whether NRF2
may play a role in our pathway. Our data showed that NRF2 is
not modulated at mRNA levels in control and TOC keratinocytes
(Supplementary Fig. 5c) as well as in the cells depleted for
iRHOM2 (Supplementary Fig. 5d). Our studies then focussed on
CYGB as it is a known p63 target gene31 and ROS scavenger32–34,
and is also transcriptionally downregulated in TOC
oesophagus35,36. Confocal analysis showed reduced CYGB
expression in the basal layer of TOC epidermis compared to
control interfollicular skin (Supplementary Fig. 5e). We also
conﬁrmed that p63 depletion led to a reduction of CYGB in
control cells by qRT-PCR. However, in TOC cells, p63 siRNA
resulted in an upregulation of CYGB expression (Supplementary
Fig. 5f). These ﬁndings observed in TOC cells with p63 siRNA are
correlated with the modulation of ROS observed in those cells.
To further support a role for iRHOM2 in CYGB regulation, an
increase in Cygb expression was observed by confocal analysis in
both back skin and footpad from rhbdf2−/− mice compared to
rhbdf2+/+ (Fig. 5d). In addition, we also conﬁrmed modulation of
CYGB expression by western blot analysis of protein extracts
derived from the back skin and paw of rhbdf2+/+ and rhbdf2−/−
mice (Fig. 5e). Similarly, shRNA knock-down of iRHOM2 showed
an upregulation of CYGB in both control and TOC keratinocytes
by western blot analysis (Fig. 5f). These data are correlated with
the observed reduction of ROS production in iRHOM2-depleted
cells and suggest a possible interaction may be occurring between
iRHOM2 and CYGB. To investigate this possible interaction,
proximity ligation assay (PLA) was performed in control
keratinocytes and showed intense signals corresponding to
formation of complexes between iRHOM2 and CYGB (Fig. 5g).
Also, co-immunoprecipitation analysis showed that endogenous
CYGB was able to efﬁciently immunoprecipitate iRHOM2 in
control keratinocytes (Supplementary Fig.5g). These data indicate
that iRHOM2 interacts with and represses CYGB, plus suggest
both p63 and iRHOM2 participate in regulating the oxidative
stress response.
SFN suppresses p63–iRHOM2 pathway in TOC. Oxidative
stress has been linked previously to palmoplantar keratoderma
associated with Keratin 16 (K16) mutations, and the use of SFN
(Sulforaphane), a natural isothiocyanate compound found in
cruciferous vegetables, rescued the palmoplantar keratoderma
phenotype in krt16−/− mice28. Furthermore our recent study12
has shown that rhbdf2−/− mice footpad showed a thinner epi-
dermis, demonstrating that iRHOM2 regulates hyperproliferation
and thickening of the palmoplantar epidermis. To explore whe-
ther SFN could affect TOC keratinocytes, cells were treated with
this compound and analysed for ROS production by ﬂow cyto-
metry. Data showed that SFN treatment signiﬁcantly reduced
ROS production in TOC keratinocytes (Fig. 6a). Moreover, the
treated TOC cells showed a signiﬁcant reduction in cell pro-
liferation (Fig. 6b) and were undergoing apoptosis (Fig. 6c). To
investigate if SFN could regulate p63–iRHOM2 and associated
downstream pathways, western blot analysis was performed and
showed a downregulation of iRHOM2, ΔNp63 and SURVIVIN
but an upregulation of CYGB following SFN treatment (Fig. 6d).
In agreement with our previous report demonstrating that
iRHOM2 regulates the stress-response keratin, K1612, a down-
regulation of K16 expression (Fig. 6d) and the collapse of K16
ﬁlaments network upon SFN treatment in TOC keratinocytes was
observed (Fig. 6e). It has been reported that apoptosis can result
in keratin solubilisation, ﬁlament reorganisation and collapse37.
In support of the positive feedback loop occurring between
ΔNp63 and iRHOM2 in hyperproliferative keratinocytes, TOC
keratinocytes silenced for p63 also demonstrated a down-
regulation of K16 (Supplementary Fig. 5h). Together, these
data support the hypothesis that SFN inhibits the
p63–iRHOM2 signalling pathway. SFN treatment reduced TOC-
cell proliferation similarly to p63 (Supplementary Fig. 3e) or
iRHOM212 downregulation. These cells also showed a reduction
of ADAM17-mediated shedding of TGFα and IL-6R (Fig. 6f).
Importantly, SFN treatment restored CYGB expression and
reduced ROS levels. Moreover, SFN-treated cells also displayed a
reduced SURVIVIN expression and were more sensitive to cell
death. The increase in apoptosis was conﬁrmed with the activa-
tion of p53 by phosphorylation of serine 15 (Fig. 6d).These
ﬁndings indicated that SFN reduces the activation of
p63–iRHOM2 pathway in TOC keratinocytes, resulting in
reduced oxidative stress, inﬂammation, proliferation, and stress-
response K16, and increased apoptosis.
Discussion
Gain-of-function mutations in RHBDF2, the gene encoding
iRHOM2, underlie Tylosis with Oesophageal Cancer (TOC)5, a
Normal state Hyperproliferative state
Low iRHOM2 activity
CYGB CYGBADAM17 ADAM17
Survivin Survivin
iRHOM2 iRHOM2
ΔNp63 ΔNp63
High iRHOM2 activity
Fig. 7 Proposed model. Model illustrating the regulation of iRHOM2–p63
pathway under normal and hyperproliferative states
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syndrome characterised by palmoplantar epidermis thickening.
We have recently shown the role of iRHOM2 in determining
footpad thickness in humans and mice12, with rhbdf2−/− mice
displaying a thinner footpad epidermis, the opposite of the phe-
notype observed in human TOC palmoplantar epidermis. These
data support an important role for iRHOM2 in regulating the
epithelial response to stress. In this present study we provide new
insights into the functional role of iRHOM2 in skin epidermal
homoeostasis. Here, iRHOM2 has been identiﬁed as a new
transcriptional target of p63 that is regulated in a cell-context-
dependent manner. Considering that iRHOM2 is a key regulator
of EGFR signalling and that iRHOM2 mutations cause an
increase in the maturation and activity of ADAM17, we investi-
gated its downstream pathway. Our data revealed that p63 has an
impact on ADAM17 and its associated substrates, demonstrating
a role of p63 in inﬂammatory skin diseases. In addition, we are
also reporting that the iRHOM2–ADAM17 axis regulates p63
expression. These ﬁndings highlight a novel regulation linking
iRHOM2 and p63 and suggest that some common pathways are
occurring in keratinocyte homoeostasis. We have recently vali-
dated a model of study12 in which we have established that mouse
footpad skin and human TOC keratinocytes are considered to be
a hyperproliferative model, compared to murine back skin and
normal keratinocytes, which are equivalent to physiological
conditions.
In the normal physiological state, such as in control kerati-
nocytes or in mouse back skin, p63 positively regulates iRHOM2
while it antagonises ΔNp63 expression (Fig. 7). Thus, in this
context, p63 depletion leads to a downregulation of its novel or
known target genes such as iRHOM2, ADAM17, SURVIVIN and
CYGB31. In contrast, iRHOM2 downregulation ‘de-represses’ p63
which in turn activates its downstream target genes such as
SURVIVIN and CYGB. Our ﬁndings emphasise a critical role for
the p63–iRHOM2 axis in normal skin. These data support pre-
vious ﬁndings showing signiﬁcant roles for both p6326,27,31 and
iRHOM212 in regulating cellular proliferation, migration and
inﬂammation.
In the hyperproliferative state, both TOC keratinocytes
depleted for iRHOM2 and rhbdf2−/− footpad skin showed a
downregulation of ΔNp63 expression. Our data highlight the fact
that inﬂammation in TOC keratinocytes supports a hyperproli-
ferative phenotype with ΔNp63 overexpression. These ﬁndings
indicate that iRHOM2 positively regulates ΔNp63 expression in
TOC. Consequently, we observed an increased expression of p63
target genes in hyperproliferative keratinocytes. Moreover, p63
depletion reduces iRHOM2 expression in TOC keratinocytes.
Thus, this indicates that there is an auto-regulatory feedback loop
occurring between iRHOM2 and ΔNp63 in the hyperproliferative
state (Fig. 7), with similar regulation in proliferation, migration
and inﬂammation.
Towards understanding the mechanisms through which TOC
keratinocytes responded to stressors, we investigated how these
cells respond to UVB treatment. This study allow us to identify
SURVIVIN as a p63 target gene, which contributes to apoptosis
resistance38, conﬁrming previous reports attributing a role in cell
survival to ΔNp63 39,40. In addition, we have shown a key role for
iRHOM2 in apoptosis via its direct regulation of SURVIVIN.
Thus, in TOC keratinocytes, p63 siRNA or shRNA knock-down
of iRHOM2 induces apoptosis and shows SURVIVIN down-
regulation. These observations conﬁrmed previous studies
demonstrating that SURVIVIN is often upregulated in cancer and
dysplasia, driving resistance to cell death and contributing to
progression of neoplasia41.
Hyperproliferation and dysregulation of apoptosis are related
to ROS production as it plays a role in these processes30. We have
identiﬁed CYGB, a known p63 target gene31, as a key modulator
of ROS production in TOC keratinocytes. Prior studies have
associated CYGB with cancer suppression42 especially in oeso-
phageal cells36, and reported a transcriptional downregulation of
CYGB in TOC. We conﬁrmed low levels of CYGB expression in
TOC and now identify CYGB as a novel interacting binding
partner of iRHOM2. Thus, either the depletion of p63 or
iRHOM2 in TOC keratinocytes, as well in rhbdf2−/− footpad
skin, increases CYGB expression, which in turn dampens ROS
release, indicating that the iRHOM2–p63 pathway inﬂuences
maintenance of redox status.
In TOC keratinocytes, the natural antioxidant compound,
sulforaphane (SFN) reduced ROS production and strikingly
inhibited the iRHOM2–p63 pathway which can drive survival
and inﬂammation. Previous studies have reported that SFN
possesses potent chemopreventive efﬁcacy in cancers43 by indu-
cing apoptosis44 and NRF2 mediated induction of phase II
detoxifying enzymes45, protecting multiple organs from oxidative
injuries46 and reducing the inﬂammatory response47. Addition-
ally, it has been well established that these different mechanisms
act synergistically48. Consistent with a recent study, oxidative
stress and dysfunctional NRF2 underlies the palmoplantar kera-
toderma disorder pachyonychia congenita associated with K16
mutations, with SFN treatment reducing the aberrant keratini-
sation in krt16 −/− mice28. Our ﬁndings demonstrate that SFN
could also be used pharmacologically in TOC keratinocytes to
target the downstream effects of the iRHOM2–p63 pathway,
especially through CYGB induction. Thus, it is noteworthy to
observe that SFN seems to mimic the depletion of p63 or
iRHOM2 in TOC keratinocytes. As we have shown previously
that rhbdf2−/− mice footpad showed a thinner epidermis12 with
absence of K16 expression, SFN treatment may have a similar
impact on the hyperproliferative skin and oesophageal phenotype
in TOC28. This study supports the model of the iRHOM2–p63
pathway regulating inﬂammation, hyperproliferation, oxidative
stress and cell survival. Thus targeting of the iRHOM2–p63 axis
in keratinisation disorders and dysplasia could have therapeutic
potential.
Methods
Cell culture and reagents. TOC cells are immortalised keratinocytes from a
Tylosis patient carrying the UK RHBDF2 mutation have been described pre-
viously5. Control keratinocytes carrying the same immortalisation with human
papilloma virus (HPV-16) open reading frames E6 and E7 as TOC cells. Cells were
cultured in DMEM (Sigma), supplemented with 10% foetal bovine serum (FBS),
1% penicillin–streptomycin (pen–strep), 100 µM L-glutamine (Sigma) and kerati-
nocyte growth supplement RM+ (RM+: containing EGF). HaCaT and HEK293
cells were cultured in DMEM supplemented with 10% FBS, 1% pen–strep and 100
µM L-glutamine. All cells were cultured in sterilised conditions at 37 °C with 5% of
CO2. RHBDF2 or negative scrambled shRNA for control and TOC keratinocytes
were previously described12.
Antibodies. The list of used antibodies is reported in Supplementary Information
(Supplementary Table 1).
Treatments. For treatment (UV-B, Phorbol 12-myristate 13-acetate (PMA),
condition media (CM), TMI005, Ca2+ and Sulforaphane (SFN)), cultured cells
were plated at the density of 2 × 105 cells in six-well plates and allowed to attach
overnight at 37 ˚C, after 24 h, cells were treated. For UV-B, cells were irradiated at
10 and 25 mJ/cm2. After UVB irradiation, the media was aspired and fresh culture
medium was added (samples untreated were just changed with fresh medium). The
cells were then harvested at 24 h post irradiation. For PMA (Sigma) treatment, the
media was supplemented by the addition of 250 ng/ml PMA for 24 h. In condition
media experiments, media from TOC keratinocytes, was centrifuged to eliminate
any cells, then ﬁltered using 0.2 µm ﬁlter (Millipore) and diluted in complete media
(1:2). After these procedures the media was added to the cells for 24 h. For TMI005
(Apratastat, 1507 Axon Medchem UK) was dissolved in dimethyl sulfoxide
(DMSO) and stock solution was freshly prepared and added to the cells at the ﬁnal
concentration of 500 nM for 24 h. The same DMSO concentration used to dilute
the TMI005 was utilised as a negative control. To induce differentiation, calcium
(2 mM) was added in the medium with 2% of FBS, when the cells until reaching
~90% conﬂuence to induced differentiation. SFN was purchased from Sigma and
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was dissolved in DMSO at the concentration of 40 mg/ml for the stock solution.
SFN was added to cell cultures to obtain the ﬁnal concentration of 10 µM, samples
were analysed after 24 and 48 h post treatment.
ChIP assay. Chromatin was prepared from normal keratinocytes and immuno-
precipitated with antipan-p63 (H137) overnight at 4 °C. ChIP assays were per-
formed as previously described21. DNA extraction was carried out with
phenol–chloroform. Puriﬁed DNA was diluted in water and subjected to qRT-PCR.
Primer sequences used: ADAM17 F: 5′-CCTCACAATACTCAGCAAAA-3′,
ADAM17 R: 5′-AGTCAGTAGGAGTGATTATG-3′; RHBDF2 F: 5′-
TGTGCCCTTGCTTACCCCTG-3′, RHBDF2 R: 5′-CACTCATTTGCTCCTCCA-
GAC-3′; BIRC5 F: 5′-CTCCTTTCCTGGTGCACCT-3′, BIRC5 R: 5′-
CGGGGTGTGGTCCCTTTGGA-3′; TK F: 5′-GTGAACTTCCCGAGGCGCAA-
3′, TK R: 5′-GCCCCTTTAAACTTGGTGGGC-3′; p21 F: 5′-ATGTA-
TAGGAGCGAAGGTGCA-3′, p21 R: 5′-CCTCCTTTCTGTGCCTGAAACA-3′;
Chr11 F: 5′-TTGCATATAAAGGAAACTGAAATGCT-3′, Chr11 R: 5′-
TTACTGCCATGGGTCCGTATC-3′.
Transfection. HEK293 cells were transfected by using Lipofectamine 2000 reagent
(Invitrogen) at a 1:2 ml/mg ratio with DNA, using 5 mg of plasmid DNA. The
plasmids for p63 overexpression were a generous gift from Dr. Eleonora Candi.
Gateway cloning and luciferase reporter assays. To generate an RHBDF2
promoter reporter vector, recombinant plasmids were constructed using the
Gateway cloning system (Invitrogen). A genomic fragment corresponding to the
promoter region of RHBDF2 was PCR ampliﬁed using primers ﬂanked by direc-
tional attB sites, after which this fragment was integrated into the pDONR221
gateway donor vector (Invitrogen) using BP clonase (Invitrogen).
The following, attB-ﬂanked, primers were used for the ampliﬁcation of the
RHBDF2 promoter region Forward:
GGGGACAAGTTTGTACAAAAAAGCAGGCTACCTGGAGGCTCACTCCAC
TCT Reverse:
GGGGACCACTTTGTACAAGAAAGCTGGGTTGGGATTACAGGCATGAG.
After transformation of OneShot TOP10 chemically competent E. coli (Thermo
Fisher) and selection using kanamycin-containing LB medium, this vector was
puriﬁed and analysed by restriction digestion using NaeI and HpaI restriction
endonucleases. Entry clones with correct integration were then used to clone the
promoter sequence into a modiﬁed pGL3-Enhancer vector (modiﬁed to contain
attR integration sites) using LR clonase (invitrogen). Once again, these vectors were
used to transform OneShot TOP10 competent E. coli, which were selected using LB
medium containing ampicillin, puriﬁed, and analysed for correct integration by
restriction digestion using EcoNI and NheI endonucleases. For luciferase reporter
assays, HEK293 cells were plated at a density of 5 × 104 cells per well into 96-well
plates. Twenty-four hours later, 50 ng of transient expression vectors encoding
either TAp63α or ΔNp63α were transfected into these HEK293 cells either alone or
alongside 50 ng of the ﬁreﬂy luciferase-expressing pGL3-RHBDF2 vector or the
positive control IRF6_BS2_p229 vector, in addition to 5 ng of an internal control
Renilla luciferase reporter vector, using lipofectamine transfection reagent. After 24
more hours, lysates were collected by treating with 20 μl passive lysis buffer per well
for 15 min. Luciferase was assayed by the Dual-Luciferase system (Promega), with
data presented as luciferase activity relative to untransfected cells.
RNA interference. For p63 knockdown, siRNA sequences against TP63 (ID
217143, ID 4893 and ID 217144 from Applied Biosystems) were used in combi-
nation to create a siRNA-p63 pool. For ADAM17 knockdown, siRNA sequences
speciﬁc to against ADAM17 (L-003453-00-0005, OnTarget plus SMARTPool
ADAM17 siRNA, Dharmacon Lafayette, USA). As a negative control, a non-
targeting siRNA pool (D-001810-10-20, ON-TARGETplus, Dharmacon Lafayette,
USA) was selected. Transfection was performed according to the manufacturer’s
protocol and optimised for a six-well plate. Normal and TOC keratinocytes were
plated at 50% conﬂuency and subjected to transfection on the following day using
the transfection reagent Dharma FECT 1 (Thermo Fisher Dharmacon) and 60 nM
ﬁnal concentration of each siRNA. During siRNA application, antibiotics were
removed from the cell culture medium. Transfection media were replaced with
complete DMEM after 24 h. p63 and ADAM17 expression were assessed by wes-
tern blot after 48 h.
Immunoblot and co-immunoprecipitation. After performing speciﬁc treatments,
cells were harvested, washed three times with phosphate-buffered saline (PBS) and
then lysed using lysis buffer [1 M Tris, 2.5 M NaCl, 10% glycerol, 0.5 M glycer-
ophosphate, 1% Tween-20, 0.5% Nonidet P-40 and EDTA-free Complete Protease
Inhibitor tablet (Roche)] for 15 min on ice. Protein concentration was measured
using a Bradford Assay Kit (Bio-Rad). Equal amounts of protein were loaded and
separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) (on 10% or 12% polyacrylamide gels) and transferred to a nitrocellulose
membrane (Whatman). The blots were incubated with the speciﬁc antibodies and
developed according to the manufacturer’s instructions (ECL Immobilion Western,
Millipore). Antibodies were diluted in PBS containing 5% milk and 0.01% Tween
20. Co-immunoprecipitation experiments were performed as previously descri-
bed12. Brieﬂy, the lysates were collected after 30 min and pre-cleared by cen-
trifugation at 13,000 rpm for 10 min at 4 °C. Protein concentration was calculated
using the Bradford Protein Assay system (Bio-Rad). In total, 50 µl of Sepharose
protein G (Amersham) were prepared according to manufacturer’s instructions.
IgG (Rabbit IgG sc-2027) was used as a control. 2 mg of protein lysate was added to
beads and antibodies (2 µg) incubated overnight at 4 °C with rotation. The fol-
lowing day beads were washed three times for 5 min on ice in 1 ml of NP-40 wash
buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% NP40) containing
protease and phosphatase inhibitors (Roche). Beads were separated from antibody-
protein complexes by boiling for 5 min in 2× Laemelli buffer and loaded onto a gel
for SDS-PAGE electrophoresis. Uncut blots are supplied in Supplementary
Figure 6.
qRT-PCR. Total RNA was prepared with RNeasy mini Kit (Qiagen). cDNA was
synthesised using High-Capacity cDNA Reverse Transcription Kits strand
(Thermo Scientiﬁc) for RT-PCR according to the manufacturer’s instructions.
Semi-quantitative PCR was carried out using Maxima SYBR Green/ROX qPCR
master mix (Thermo Scientiﬁc, UK). Measurements were done in triplicate and
normalised to levels of GAPDH mRNA for each reaction and analysed using the
equation n= 2−ΔΔCt. The following primers were used for qPCR analysis: for
human genes GAPDH forward 5′-GGAGTCAACGGATTTGGTC-3′ and reverse
5′-GGCAACAATATCCACTTTACC-3′; ΔNp63 forward 5′-GAGTTCTGT-
TATCTTCTTAG-3′ and reverse 5′-TGTTCTGCGCGTGGTCTG-3′;; HMOX1
forward 5′-AAAGTGCAAGATTCTGCCC-3′ and reverse 5′-GAGTGTAAG-
GACCCATCGG-3′; NQO1 forward 5′-TCTATGCCATGAACTTCAATCC-3′ and
reverse 5′-CTTCAGTTTACCTGTGATGTC-3′; SOD1 forward 5′-GGATGAA-
GAGAGGCATGTTGGAGAC-3′ and reverse 5′-GTCTTTGTACTTTCTT-
CATTTCCACC-3′; CYGB forward 5′-CTGTCGTGGA GAACCTGCAT-3′ and 5′-
TGGAGTTAGGGGTCCTACGG-3′; RHBDF2 forward 5′-GGGCAAACTCA-
GACTCGAAG-3′ and reverse 5′-CGCTGACTCCAAACCACTG-3′, ADAM17
forward 5′-GGTTCCTTTCGTGCTGGCGC-3′ and reverse 5′-AAGCTTCTC-
GAGTCTCTGGTGGG-3′; NRF2 forward 5′-CAGCGACGGAAAGAGTATGA-3′
and reverse 5′-TGGGCAACCTGGGAGTAG-3′. For mouse genes ΔNp63 forward
5′-GTACCTGGAAAACAATGCCCAG-3′ and reverse 5′-
CGCTATTCTGTGCCTGGTCTG-3′; GAPDH forward 5′-ACCA-
CAGTCCATGCCATCAC-3′ and reverse 5′-TCCACCACCCTGTTGCTGTA-3′.
The enzyme-linked immunosorbent assay (ELISA). After performing speciﬁc
treatments, cell culture supernatants were used to detect TNF-α, IL-6R and TGF-α
by ELISA using the human DuoSet ELISA kit as to the manufacturer’s instructions
(R&D System, UK). Results were expressed as means of four independent
experiments with triplicate samples.
Immunoﬂuorescence. Immunohistochemistry was performed on 5 mm frozen
tissue or on cells plated in cover slips; sections were air-dried before processed.
Cells/tissues were ﬁxed in 4% paraformaldehyde (PFA) or in ice cold
methanol–acetone (50:50 mixture) at room temperature for 15 min. If PFA ﬁxation
was used, samples were permeabilized with 0.1% Triton X-100. Cells/tissues were
washed three times with PBS for 5 min each and incubated with 5% goat serum in
PBS for 1 hour at room temperature to reduce nonspeciﬁc binding. After the cells/
tissue were incubated with primary antibody in 5% goat serum overnight at 4 ˚C.
The following day cells/tissues were washed three times with PBS and incubated
with the secondary antibody conjugated with Alexa Fluor (Molecular Probes) in 5%
goat serum for 1 h at room temperature. After three washes, cells/sections were
incubated for 10 min with DAPI (100 ng/ml). Cells/tissues were mounted onto
slides using Vectashield Mounting Medium (Vector Laboratories). Fluorescence
was evaluated in one single plane by Zeiss 710 confocal microscopy (Carl Zeiss).
Haematoxylin and eosin (H&E). Tissue sections were ﬁxed in 4% PFA and stained
with haematoxylin and eosin.
Cell proliferation. To analyse cell proliferation after performing transfection with
siRNA, cells were plated at a seeding density of 1 × 104 per well and then harvested
at 24 and 48 h. For SFN exposure, cells were seeded at 1 × 104 per well and then
treated with SFN at 10 µM. Cells were counted after 24 and 48 h post treatment.
Cell counts were performed using the Nucleocounter/Nucleocasette system (Che-
moMetec, Denmark). Each experiment was repeated three times with triplicate
samples.
Scratch assay. Cells were seeded into six-well plates in culture medium and were
transfected with siRNA. The cells were incubated with mitomycin C (400 ng/ml,
Roche) for 45 min to prevent proliferation. The scratch wound was created verti-
cally to the centre of the well using a sterile tip to 200 µl. The cells were subse-
quently washed with PBS to remove the detached cells and then replenished with
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fresh medium. The wound was monitored and photographed immediately (time 0)
and after 24 h from the creation of the scratch using a phase-contrast microscope.
The wound area was evaluated by using Image J Software. The percentage was
calculated using the following equation: [Wound area (0h)−wound area
(Xh)]×100/wound area (0h)=% wound closure.
Annexin V assay. Apoptosis was assessed by ﬂow cytometry using FITC Annexin-
V (Becton Dickinson) and DAPI. The cells were harvested by the addition of
trypsin, centrifuged for 5 min at 1200 rpm, and washed with PBS. Cells were
stained with FITC-Annexin V for 15 min and the DAPI (200 ng/ml) was added.
Samples were analysed by a BD FACSCanto ІІ Flow Cytometer (BD, UK). Data
were expressed as means of total apoptosis, the sum of early and late apoptosis. The
gating strategy is reported in Supplementary Fig.7.
Proximity ligation assay. PLA was performed using the Duolink in situ kit
(Sigma) according to the manufacturer’s instructions. Cells were plated on cov-
erslips in 12-well plates and after 24 h ﬁxed with methanol acetone or PFA. Fol-
lowing ﬁxation, cells were incubated in Duolink blocking solution for 30 min at 37 °
C. Primary antibodies were diluted in Duolink Antibody diluent and added to the
cells overnight at 4 °C. The following day the cells were washed in Wash buffer A
two times for 5 min. The PLA plus and minus probes were diluted in antibody
diluent and added to the cells, then incubated for 1 h at 37 °C. The cells were
washed in Wash buffer A two times for 5 min. The ligation-ligase was prepared
according to instructions and applied to cells for 30 min at 37 °C. After
washes, ampliﬁcation with Duolink Ampliﬁcation-Polymerase solution was per-
formed for 100 min at 37 °C. The cells were washed in Wash Buffer B two times for
10 min and then mounted with Duolink in situ mounting medium with DAPI
before visualisation with Zeiss 710 confocal microscopy (Carl Zeiss). As a positive
control binding between K6 and K16 was analysed, while as a negative control no
primary antibodies were applied. Quantiﬁcations were performed using Image J
Software.
Measurement of ROS production. The quantiﬁcation of intracellular ROS was
based on the oxidation of dihydroethidium (DHE, Thermo Fisher). Brieﬂy, normal
and TOC keratinocytes (2 × 105) were plated in each well of six-well plate. Cells
were then washed twice with PBS and incubated with DHE (5 µM) at 37 °C for 30
min in the dark. After incubation, the cell were washed twice with PBS and were
analysed by a BD FACSCanto ІІ Flow Cytometer (BD, UK). Data represented the
value of ROS in the live cells by a ratio referred to the control. For staining, normal
and TOC keratinocytes (5 × 104) were plated on cover slip in each well of 12-well
plate. The cells on cover slip were washed twice with HBSS after exposure to DHE
(Thermo Scientiﬁc) working concentration (5 µM) at 37 °C for 30 min in the dark.
Before microscopy, Hoechst 33342 (0.1 μg/ml, Thermo Scientiﬁc) was added to
stain the nuclei. The ﬂuorescence was analysed using Zeiss 710 confocal micro-
scopy (Carl Zeiss).
Mouse studies. rhbdf2−/−mice were generated as previously described12. The fore
paw footpad epidermis from 20-week-old rhbdf2−/− or WT female mice were
dissected and ﬁxed in OCT on dry ice. Immunohistochemical staining was per-
formed as previously described and visualised using the Zeiss 710 Confocal
Microscope (Carl Zeiss). Biopsies from WT female mice (n= 6 per genotype, back
and paw skin) were snap frozen, pulverised, and dissolved in TRIzol reagent for
RNA preparation (Invitrogen) according to manufacturer’s protocol. RNA samples
were treated with RNase-free DNaseI (Qiagen). Western blot analysis of mouse
skin extract were prepared in urea buffer 8M (8M urea, 1 M thiourea, 0.5%
CHAPS, 50 mM DTT, 24 mM spermine).
Study approval. All experiments involving mice followed the UK Animal Welfare
Act guidelines and were approved by the UK Home Ofﬁce (PPL 70/7665). Human
skin biopsies were approved by the research ethics committees of the National
Health Service (08/H1102/73) and informed consent was obtained from
participants.
Statistical analysis. All statistical analyses were performed with Prism 6 Software
(GraphPad). Data were analysed by the unpaired/paired two-tailed Student’s t test
and one way ANOVA Dunnett’s multiple comparison test. All experiments were
performed at least three times independently or more indicated in the legends. The
data are expressed as the mean ± standard error of mean (SEM).
*p < 0.05, **p < 0.01 and ***p < 0.001.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding authors (D.P.K., A.C.) upon reasonable request.
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